NASDAQ

MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX)

♥ 646 Thanks from members

Live price chart, market sentiment, and community perspectives for MoonLake Immunotherapeutics (NASDAQ: MLTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: MoonLake Immunotherapeutics FoundersLeadership: Dr. Kristian Reich (CEO)Leadership: Brian Dow (CFO)Holder: Bain Capital Life SciencesHolder: RTW InvestmentsHolder: FidelitySonelokimab (M1095)#MoonLake Immunotherapeutics#MLTX stock#Biotech#Nanobody Therapeutics#NASDAQ MLTX